DNA damage signaling induced by the G-quadruplex ligand 12459 is modulated by PPM1D/WIP1 phosphatase

Nucleic Acids Research

Volumn 41, Issue 6, 2013, Pages 3588-3599

  Douarre, Céline ^a,d   Mergui, Xénia ^b   Sidibe, Assitan ^b   Gomez, Dennis ^c   Alberti, Patrizia ^b   Mailliet, Patrick ^b   Trentesaux, Chantal ^a,b   Riou, Jean François ^b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ATR PROTEIN; CHECKPOINT KINASE 1; COMPOUND 12459; DNA; GAMMA HISTONE H2AX; HISTONE; PHOSPHATASE; PROTEIN PHOSPHATASE MAGNESIUM DEPENDENT 1D PROTEIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG; WILD TYPE P53 INDUCED PHOSPHATASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL PROTECTION; CELL STRAIN A549; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TELOMERE;

APOPTOSIS; CELL AGING; CELL LINE, TUMOR; CELL NUCLEOLUS; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN KINASES; QUINOLINIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TELOMERE; TRIAZINES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84876047695     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt073     Document Type: Article

References (57)

1. O'Sullivan, R.J. and Karlseder, J. (2010) Telomeres: protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol., 11, 171-181.
2. Martinez,P. and Blasco, M.A. (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer, 11, 161-176.
3. Cesare, A.J. and Reddel, R.R. (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet., 11, 319-330.
4. Phan, A.T. (2010) Human telomeric G-quadruplex: structures of DNA and RNA sequences. FEBS J., 277, 1107-1117.
5. Haider, S.M., Neidle,S. and Parkinson, G.N. (2011) A structural analysis of G-quadruplex/ligand interactions. Biochimie, 93, 1239-1251.
6. Bryan, T.M. and Baumann, P. (2011) G-Quadruplexes: from guanine gels to chemotherapeutics. Mol. Biotechnol., 49, 198-208.
7. De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.F. and Mergny, J.L. (2008) Targeting telomeres and telomerase. Biochimie, 90, 131-155.
8. Lipps, H.J. and Rhodes, D. (2009) G-quadruplex structures: in vivo evidence and function. Trends Cell Biol., 19, 414-422.
9. Huppert, J.L. (2010) Structure, location and interactions of G-quadruplexes. FEBS J., 277, 3452-3458.
10. Neidle, S. (2010) Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J., 277, 1118-1125.
11. Monchaud,D. and Teulade-Fichou, M.P. (2008) A hitchhiker's guide to G-quadruplex ligands. Org. Biomol. Chem., 6, 627-636.
12. Temime-Smaali, N., Guittat, L., Sidibe, A., Shin-ya, K., Trentesaux,C. and Riou, J.F. (2009) The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells. PLoS One, 4, e6919.
13. Casagrande, V., Salvati, E., Alvino, A., Bianco, A., Ciammaichella, A., D'Angelo, C., Ginnari-Satriani, L., Serrilli, A.M., Iachettini, S., Leonetti, C. et al. (2011) N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage. J. Med. Chem., 54, 1140-1156.
14. Gomez, D., Wenner, T., Brassart, B., Douarre, C., O'Donohue, M.F., El Khoury, V., Shin-ya, K., Morjani, H., Trentesaux,C. and Riou, J.F. (2006) Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J. Biol. Chem., 281, 38721-38729.
15. Rizzo, A., Salvati, E., Porru, M., D'Angelo, C., Stevens, M.F., D'Incalci, M., Leonetti, C., Gilson, E., Zupi,G. and Biroccio, A. (2009) Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Res., 37, 5353-5364.
16. Rodriguez, R., Muller, S., Yeoman, J.A., Trentesaux, C., Riou, J.F. and Balasubramanian, S. (2008) A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J. Am. Chem. Soc., 130, 15758-15759.
17. Salvati, E., Leonetti, C., Rizzo, A., Scarsella, M., Mottolese, M., Galati, R., Sperduti, I., Stevens, M.F., D'Incalci, M., Blasco, M. et al. (2007) Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J. Clin. Invest., 117, 3236-3247.
18. Rodriguez, R., Miller, K.M., Forment, J.V., Bradshaw, C.R., Nikan, M., Britton, S., Oelschlaegel, T., Xhemalce, B., Balasubramanian,S. and Jackson, S.P. (2012) Small-molecule-induced DNA damage identifies alternative DNA structures in human genes. Nat. Chem. Biol., 8, 301-310.
19. Palm,W. and de Lange, T. (2008) How shelterin protects Mammalian telomeres. Annu. Rev. Genet., 42, 301-334.
20. Verdun, R.E. and Karlseder, J. (2006) The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell, 127, 709-720.
21. Pennarun, G., Hoffschir, F., Revaud, D., Granotier, C., Gauthier, L.R., Mailliet, P., Biard, D.S. and Boussin, F.D. (2010) ATR contributes to telomere maintenance in human cells. Nucleic Acids Res., 38, 2955-2963.
22. Arnoult, N., Shin-ya,K. and Londono-Vallejo, J.A. (2008) Studying telomere replication by Q-CO-FISH: the effect of telomestatin, a potent G-quadruplex ligand. Cytogenet. Genome Res., 122, 229-236.
23. Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., Ohyashiki, J.H. and Ohyashiki, K. (2003) Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene, 22, 5338-5347.
24. Pennarun, G., Granotier, C., Hoffschir, F., Mandine, E., Biard, D., Gauthier, L.R. and Boussin, F.D. (2008) Role of ATM in the telomere response to the G-quadruplex ligand 360A. Nucleic Acids Res., 36, 1741-1754.
25. Riou, J.F., Guittat, L., Mailliet, P., Laoui, A., Renou, E., Petitgenet, O., Megnin-Chanet, F., Hélène,C. and Mergny, J.L. (2002) Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl Acad. Sci. USA, 99, 2672-2677.
26. Gomez, D., Aouali, N., Londono-Vallejo, A., Lacroix, L., Megnin-Chanet, F., Lemarteleur, T., Douarre, C., Shin-ya, K., Mailliet, P., Trentesaux, C. et al. (2003) Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J. Biol. Chem., 278, 50554-50562.
27. Gomez, D., Aouali, N., Renaud, A., Douarre, C., Shin-ya, K., Tazi, J., Martinez, S., Trentesaux, C., Morjani,H. and Riou, J.F. (2003) Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Cancer Res., 63, 6149-6153.
28. Douarre, C., Gomez, D., Morjani, H., Zahm, J.M., O'Donohue, M.F., Eddabra, L., Mailliet, P., Riou, J.F. and Trentesaux, C. (2005) Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res., 33, 2192-2203.
29. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. and Bonner, W.M. (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273, 5858-5868.
30. de Lange, T. (2009) How telomeres solve the end-protection problem. Science, 326, 948-952.
31. Lavin, M.F. and Gueven, N. (2006) The complexity of p53 stabilization and activation. Cell Death Differ., 13, 941-950.
32. Kapoor,M. and Lozano, G. (1998) Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl Acad. Sci. USA, 95, 2834-2837.
33. Jackson, M.W., Agarwal, M.K., Agarwal, M.L., Agarwal, A., Stanhope-Baker, P., Williams, B.R. and Stark, G.R. (2004) Limited role of N-terminal phosphoserine residues in the activation of transcription by p53. Oncogene, 23, 4477-4487.
34. Moon, S.H., Nguyen, T.A., Darlington, Y., Lu,X. and Donehower, L.A. (2010) Dephosphorylation of gamma-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle, 9, 2092-2096.
35. Takekawa, M., Adachi, M., Nakahata, A., Nakayama, I., Itoh, F., Tsukuda, H., Taya,Y. and Imai, K. (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J., 19, 6517-6526.
36. Lu, X., Bocangel, D., Nannenga, B., Yamaguchi, H., Appella,E. and Donehower, L.A. (2004) The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol. Cell, 15, 621-634.
37. Incles, C.M., Schultes, C.M., Kempski, H., Koehler, H., Kelland, L.R. and Neidle, S. (2004) A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol. Cancer Ther., 3, 1201-1206.
38. Ward, I.M. and Chen, J. (2001) Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem., 276, 47759-47762.
39. Ward, I.M., Minn,K. and Chen, J. (2004) UV-induced ataxia-telangiectasia- mutated and Rad3-related (ATR) activation requires replication stress. J. Biol. Chem., 279, 9677-9680.
40. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J. and Sedivy, J.M. (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell, 14, 501-513.
41. Jullien, L., Mestre, M., Roux,P. and Gire, V. (2012) Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res., 41, 900-911.
42. Lossaint, G., Besnard, E., Fisher, D., Piette,J. and Dulic, V. (2011) Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene, 30, 4261-4274.
43. Poehlmann, A., Habold, C., Walluscheck, D., Reissig, K., Bajbouj, K., Ullrich, O., Hartig, R., Gali-Muhtasib, H., Diestel, A., Roessner, A. et al. (2011) Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G(2) checkpoint arrest. J. Cell Mol. Med., 15, 1528-1541.
44. Stiff, T., Walker, S.A., Cerosaletti, K., Goodarzi, A.A., Petermann, E., Concannon, P., O'Driscoll,M. and Jeggo, P.A. (2006) ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J., 25, 5775-5782.
45. Tahara, H., Shin-ya, K., Seimiya, H., Yamada, H., Tsuruo,T. and Ide, T. (2006) G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 30 telomeric overhang in cancer cells. Oncogene, 25, 1955-1966.
46. Tran, P.L., Largy, E., Hamon, F., Teulade-Fichou, M.P. and Mergny, J.L. (2011) Fluorescence intercalator displacement assay for screening G4 ligands towards a variety of G-quadruplex structures. Biochimie, 93, 1288-1296.
47. Deng, Z., Norseen, J., Wiedmer, A., Riethman,H. and Lieberman, P.M. (2009) TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell, 35, 403-413.
48. Fiscella, M., Zhang, H., Fan, S., Sakaguchi, K., Shen, S., Mercer, W.E., Vande Woude, G.F., O'Connor, P.M. and Appella, E. (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl Acad. Sci. USA, 94, 6048-6053.
49. Le Guezennec,X. and Bulavin, D.V. (2010) WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci., 35, 109-114.
50. Moon, S.H., Lin, L., Zhang, X., Nguyen, T.A., Darlington, Y., Waldman, A.S., Lu,X. and Donehower, L.A. (2010) Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J. Biol. Chem., 285, 12935-12947.
51. Macurek, L., Lindqvist, A., Voets, O., Kool, J., Vos, H.R. and Medema, R.H. (2010) Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene, 29, 2281-2291.
52. Cha, H., Lowe, J.M., Li, H., Lee, J.S., Belova, G.I., Bulavin, D.V. and Fornace, A.J. Jr (2010) Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. Cancer Res., 70, 4112-4122.
53. Lindqvist, A., de Bruijn, M., Macurek, L., Bras, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg,O. and Medema, R.H. (2009) Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J., 28, 3196-3206.
54. Wesierska-Gadek, J., Schloffer, D., Kotala,V. and Horky, M. (2002) Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int. J. Cancer, 101, 128-136.
55. Meek, D.W. and Cox, M. (2011) Induction and activation of the p53 pathway: a role for the protein kinase CK2? Mol. Cell. Biochem., 356, 133-138.
56. Cox, M.L. and Meek, D.W. (2010) Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. Cell Signal., 22, 564-571.
57. von Zglinicki, T., Saretzki, G., Ladhoff, J., d'Adda di Fagagna,F. and Jackson, S.P. (2005) Human cell senescence as a DNA damage response. Mech. Ageing. Dev., 126, 111-117.